$7.41
-0.11-1.46%
In chiusura: -
$7.41
0.000.00%
After hour: Oct 3, 4:00 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Gyre Therapeutics Inc (NASDAQ:GYRE) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 1.74M a 1.62M. Questo rappresenta il 10.64% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Gyre Therapeutics Corp (XNAS:GYRE) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 101.19K azioni scambiate al giorno, ci vorrebbero 16 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
1.62M
Vendite allo scoperto %
10.6%
Giorni di copertura
16
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
GYRE | Gyre Therapeutics, Inc. Common | 09/15/2025 | 09/24/2025 | 10.64% | 15,218,298 | 1,618,588 | 101,190 | 16 | |
GYRE | Gyre Therapeutics, Inc. Common | 08/29/2025 | 09/10/2025 | 11.43% | 15,218,298 | 1,739,858 | 93,593 | 18.59 | |
GYRE | Gyre Therapeutics, Inc. Common | 08/15/2025 | 08/26/2025 | 11.65% | 15,218,298 | 1,772,817 | 83,566 | 21.21 | |
GYRE | Gyre Therapeutics, Inc. Common | 07/31/2025 | 08/11/2025 | 12.59% | 14,714,784 | 1,852,217 | 74,675 | 24.8 | |
GYRE | Gyre Therapeutics, Inc. Common | 07/15/2025 | 07/24/2025 | 12.28% | 14,714,784 | 1,806,857 | 110,404 | 16.37 | |
GYRE | Gyre Therapeutics, Inc. Common | 06/30/2025 | 07/10/2025 | 12.26% | 14,714,784 | 1,804,234 | 253,151 | 7.13 | |
GYRE | Gyre Therapeutics, Inc. Common | 06/13/2025 | 06/25/2025 | 9.58% | 14,714,784 | 1,410,123 | 252,961 | 5.57 | |
GYRE | Gyre Therapeutics, Inc. Common | 05/30/2025 | 06/10/2025 | 9.66% | 14,714,784 | 1,421,641 | 546,003 | 2.6 | |
GYRE | Gyre Therapeutics, Inc. Common | 05/15/2025 | 05/27/2025 | 19.82% | 12,492,562 | 2,475,431 | 118,003 | 20.98 | |
GYRE | Gyre Therapeutics, Inc. Common | 04/30/2025 | 05/09/2025 | 13.46% | 17,593,457 | 2,367,978 | 96,432 | 24.56 | |
GYRE | Gyre Therapeutics, Inc. Common | 04/15/2025 | 04/25/2025 | 14.19% | 17,593,457 | 2,496,324 | 209,435 | 11.92 | |
GYRE | Gyre Therapeutics, Inc. Common | 03/31/2025 | 04/09/2025 | 16.45% | 14,513,438 | 2,387,452 | 311,939 | 7.65 | |
GYRE | Gyre Therapeutics, Inc. Common | 03/14/2025 | 03/25/2025 | 10.52% | 14,513,438 | 1,526,887 | 114,907 | 13.29 | |
GYRE | Gyre Therapeutics, Inc. Common | 02/28/2025 | 03/11/2025 | 20.02% | 6,723,268 | 1,346,149 | 59,319 | 22.69 | |
GYRE | Gyre Therapeutics, Inc. Common | 02/14/2025 | 02/26/2025 | 18.66% | 6,723,268 | 1,254,517 | 46,717 | 26.85 | |
GYRE | Gyre Therapeutics, Inc. Common | 01/31/2025 | 02/11/2025 | 18.57% | 6,723,268 | 1,248,253 | 62,409 | 20 | |
GYRE | Gyre Therapeutics, Inc. Common | 01/15/2025 | 01/27/2025 | 18.78% | 6,723,268 | 1,262,551 | 147,330 | 8.57 | |
GYRE | Gyre Therapeutics, Inc. Common | 12/31/2024 | 01/10/2025 | 14.16% | 6,723,268 | 952,311 | 118,545 | 8.03 | |
GYRE | Gyre Therapeutics, Inc. Common | 12/13/2024 | 12/24/2024 | 12.38% | 6,723,268 | 832,149 | 171,877 | 4.84 | |
GYRE | Gyre Therapeutics, Inc. Common | 11/29/2024 | 12/10/2024 | 8.17% | 6,723,268 | 549,379 | 82,102 | 6.69 | |
GYRE | Gyre Therapeutics, Inc. Common | 11/15/2024 | 11/26/2024 | 5.98% | 6,723,268 | 401,743 | 71,314 | 5.63 | |
GYRE | Gyre Therapeutics, Inc. Common | 10/31/2024 | 11/11/2024 | 2.63% | 14,325,180 | 376,581 | 29,283 | 12.86 | |
GYRE | Gyre Therapeutics, Inc. Common | 10/15/2024 | 10/24/2024 | 3.13% | 14,325,180 | 448,696 | 35,355 | 12.69 | |
GYRE | Gyre Therapeutics, Inc. Common | 09/30/2024 | 10/09/2024 | 3.19% | 14,325,180 | 457,298 | 80,808 | 5.66 | |
GYRE | Gyre Therapeutics, Inc. Common | 09/13/2024 | 09/24/2024 | 2.15% | 14,325,180 | 308,405 | 58,665 | 5.26 | |
GYRE | Gyre Therapeutics, Inc. Common | 08/30/2024 | 09/11/2024 | 2.18% | 14,325,180 | 312,978 | 45,125 | 6.94 | |
GYRE | Gyre Therapeutics, Inc. Common | 08/15/2024 | 08/26/2024 | 2.35% | 14,325,180 | 336,469 | 57,321 | 5.87 | |
GYRE | Gyre Therapeutics, Inc. Common | 07/31/2024 | 08/09/2024 | 4.98% | 6,411,112 | 319,343 | 44,794 | 7.13 | |
GYRE | Gyre Therapeutics, Inc. Common | 07/15/2024 | 07/24/2024 | 4.55% | 6,411,112 | 291,517 | 48,637 | 5.99 | |
GYRE | Gyre Therapeutics, Inc. Common | 06/28/2024 | 07/10/2024 | 2.71% | 6,411,112 | 173,599 | 149,215 | 1.16 | |
GYRE | Gyre Therapeutics, Inc. Common | 06/14/2024 | 06/26/2024 | 2.95% | 6,411,112 | 189,075 | 41,718 | 4.53 | |
GYRE | Gyre Therapeutics, Inc. Common | 05/31/2024 | 06/11/2024 | 3.17% | 6,411,112 | 203,275 | 75,395 | 2.7 | |
GYRE | Gyre Therapeutics, Inc. Common | 05/15/2024 | 05/24/2024 | 2.65% | 6,411,112 | 169,640 | 56,070 | 3.03 | |
GYRE | Gyre Therapeutics, Inc. Common | 04/30/2024 | 05/09/2024 | 1.19% | 6,411,112 | 76,070 | 64,871 | 1.17 | |
GYRE | Gyre Therapeutics, Inc. Common | 04/15/2024 | 04/24/2024 | 2.86% | 6,367,668 | 181,868 | 79,177 | 2.3 | |
GYRE | Gyre Therapeutics, Inc. Common | 03/28/2024 | 04/09/2024 | — | — | 121,193 | 52,658 | 2.3 | |
GYRE | Gyre Therapeutics, Inc. Common | 03/15/2024 | 03/26/2024 | — | — | 125,201 | 44,180 | 2.83 | |
GYRE | Gyre Therapeutics, Inc. Common | 02/29/2024 | 03/11/2024 | — | — | 139,690 | 127,932 | 1.09 | |
GYRE | Gyre Therapeutics, Inc. Common | 02/15/2024 | 02/27/2024 | — | — | 156,334 | 96,428 | 1.62 | |
GYRE | Gyre Therapeutics, Inc. Common | 01/31/2024 | 02/09/2024 | — | — | 210,013 | 94,880 | 2.21 | |
GYRE | Gyre Therapeutics, Inc. Common | 01/12/2024 | 01/24/2024 | — | — | 236,139 | 88,696 | 2.66 | |
GYRE | Gyre Therapeutics, Inc. Common | 12/29/2023 | 01/10/2024 | — | — | 305,849 | 77,576 | 3.94 | |
GYRE | Gyre Therapeutics, Inc. Common | 12/15/2023 | 12/27/2023 | — | — | 204,410 | 170,449 | 1.2 | |
GYRE | Gyre Therapeutics, Inc. Common | 11/30/2023 | 12/11/2023 | — | — | 265,535 | 204,537 | 1.3 | |
GYRE | Gyre Therapeutics, Inc. Common | 11/15/2023 | 11/27/2023 | — | — | 48,782 | 41,314 | 1.18 | |
GYRE | Gyre Therapeutics, Inc. Common | 10/31/2023 | 11/09/2023 | — | — | 81,615 | 35,133 | 2.32 |
In cerca di azioni più vendute allo scoperto?